Fevzi Yalniz

5PUBLICATIONS
26CO-AUTHORS
Haematological tumoursEnvironmental epidemiologyMedical virologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 13, 2024
Unveiling the Genetic and Clinical Differences of Acute Myeloid Leukemia (AML) in Obese Patients.

Fevzi F Yalniz, Anna Johnson, Yanal Alnimer

|Jul 15, 2021
CRP and ferritin in addition to the EASIX score predict CAR-T-related toxicity.

Uri Greenbaum, Paolo Strati, Rima M Saliba

|Feb 27, 2020
Significance of minimal residual disease monitoring by real-time quantitative polymerase chain reaction in core binding factor acute myeloid leukemia for transplantation outcomes.

Fevzi F Yalniz, Keyur P Patel, Qaiser Bashir

|Aug 31, 2019
A phase II study of addition of pracinostat to a hypomethylating agent in patients with myelodysplastic syndromes who have not responded to previous hypomethylating agent therapy.

Fevzi F Yalniz, Jesus G Berdeja, Michael B Maris

|Jun 26, 2019
Prognostic significance of baseline FLT3-ITD mutant allele level in acute myeloid leukemia treated with intensive chemotherapy with/without sorafenib.

Fevzi Yalniz, Iman Abou Dalle, Hagop Kantarjian

Pageof 1

Frequent Collaborators

1 joint publications

Guillermo Garcia-Manero

1 joint publications

Stefan O Ciurea

1 joint publications

Uday R Popat

1 joint publications

Betül Oran